Three Part Series on Thimerosal and Vaccines by F. Edward Yazbak MD, FAAP
Posted May 01 2011 12:00am
Below are three articles by Dr. Edward Yazbak on Thimerosal and vaccinations:
Thimerosal Containing Vaccines, Part I In the Dark by F. Edward Yazbak MD, FAAP Read Part I HERE
This series on thimerosal-containing vaccines (TCV) is a critical review of the subject and what is known about it at this time. (Spring 2011)
Thimerosal is not my primary area of interest. I therefore promise to be extra careful documenting the facts and even more careful commenting on them.
Because the CDC only promotes vaccines and vaccination, the write-up about Thimerosal in vaccines on the CDC web site is relatively shortThimerosal is a mercury-containing preservative used in some vaccines and other products since the 1930's. There is no convincing evidence of harm caused by the low doses of thimerosal in vaccines, except for minor reactions like redness and swelling at the injection site. However, in July 1999, the Public Health Service agencies, the American Academy of Pediatrics, and vaccine manufacturers agreed that thimerosal should be reduced or eliminated in vaccines as a precautionary measure.
The featured article on the World Health Organization (WHO) web site on March 15, 2011 was, as expected, about the “Japanese government taking appropriate protective measures” by asking people living within 20 km of the Fukushima Daiichi nuclear power plant to evacuate and those between 20 km and 30 km to stay indoors in unventilated rooms. The detailed information about the catastrophe was presented as several well written pages of questions and answers starting with the all-important: “What is the current risk of radiation-related health problems in Japan to those near the reactor at the time, and those in other parts of Japan?”
WHO was doing what it was supposed to do!
It was responding to a health threat and informing everyone in a balanced scientific and timely fashion!
PubMed is a service of the US National Library of Medicine (NLM) of the US National Institutes of Health. According to its main page, “PubMed comprises more than 20 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.”
On March 25, 2011, I accessed PubMed and searched for “thimerosal, vaccine”.
I found 396 citations, the most recent of which (listed as # 1- PMID: 21350943) published on-line February 25, 2011. It was titled “Integrating Experimental (In Vitro and In Vivo) Neurotoxicity Studies of Low-dose Thimerosal Relevant to Vaccines” and authored by Dr. J G Dórea of the Faculty of Health Sciences, Universidade de Brasília, Brazil. This article will be discussed in some detail later.
Readers interested in following this discussion may want to access PubMed at http://www.ncbi.nlm.nih.gov/pubmed/ . Alternative searches for “thimerosal vaccine”, “vaccine, thimerosal” or “vaccine thimerosal” will also lead to the same listing.